Centocor, Inc. et al v. Abbott Laboratories, No. 2:07-cv-00139 (E.D. Tex. Apr. 6, 2009)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

I. Introduction In this case, the plaintiffs, Centocor, Inc. and New York University (collectively, “plaintiffs”), contend that the defendants, Abbot t Laboratories, Abbott Bioresearch Center, Inc., and Abbott Biotechnology Ltd. (coll ectively, “defendants”), infringe various claims of United States Patent Nos. 7,070,775 (“the ‘775 patent”) and 7,276,239 (“the ‘239 patent”). This order addresses the parties’ various claim construction disputes.